共 50 条
- [42] Anti-vascular endothelial growth factor for neovascular age-related macular degeneration in 2022: Same, same but different CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2022, 50 (03): : 270 - 273
- [45] ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION Outcomes in Eyes With Poor Initial Vision RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2015, 35 (10): : 1957 - 1963
- [46] Outcomes of cataract surgery in patients with neovascular age-related macular degeneration in the era of anti-vascular endothelial growth factor therapy JOURNAL OF CATARACT AND REFRACTIVE SURGERY, 2012, 38 (04): : 677 - 682
- [50] Development of ranibizumab, an anti-vascular endothelial growth factor antigen binding fragment, as therapy for neovascular age-related macular degeneration RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2006, 26 (08): : 859 - 870